Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting2
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown125%
recruiting250%
completed125%

Recent Activity

2 active trials
Showing 4 of 4
recruiting

Sequent Extended Study

NCT05788432
recruiting

STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)

NCT05438121
completednot_applicable

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

NCT05096442
unknownnot_applicable

The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis

NCT04733443

Clinical Trials (4)

Showing 4 of 4 trials
NCT05788432

Sequent Extended Study

Recruiting
NCT05438121

STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)

Recruiting
NCT05096442Not Applicable

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

Completed
NCT04733443Not Applicable

The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4